SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-021827
Filing Date
2018-04-23
Accepted
2018-04-23 16:16:45
Documents
74
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F tv489181_20f.htm 20-F 1188658
2 EXHIBIT 12.1 tv489181_ex12-1.htm EX-12.1 8021
3 EXHIBIT 12.2 tv489181_ex12-2.htm EX-12.2 7997
4 EXHIBIT 13.1 tv489181_ex13-1.htm EX-13.1 3701
5 EXHIBIT 13.2 tv489181_ex13-2.htm EX-13.2 3889
6 EXHIBIT 15.1 tv489181_ex15-1.htm EX-15.1 3163
7 GRAPHIC tv489181_img1.jpg GRAPHIC 5611
8 GRAPHIC tv489181_img2.jpg GRAPHIC 73079
9 GRAPHIC tv489181_img3.jpg GRAPHIC 127885
  Complete submission text file 0001144204-18-021827.txt   4717872

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT orpn-20171231.xml EX-101.INS 821526
11 XBRL TAXONOMY EXTENSION SCHEMA orpn-20171231.xsd EX-101.SCH 37694
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orpn-20171231_cal.xml EX-101.CAL 33943
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orpn-20171231_def.xml EX-101.DEF 221968
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE orpn-20171231_lab.xml EX-101.LAB 254505
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orpn-20171231_pre.xml EX-101.PRE 269482
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36578 | Film No.: 18769069
SIC: 2834 Pharmaceutical Preparations